Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5813 posts found.

WHO reject convalescent plasma treatment for COVID-19

December 7, 2021 Manufacturing and Production

WHO now strongly recommend against the use of convalescent plasma in the treatment of COVID-19 patients regardless of their stage …
News

Study reveals young people recover quickly from rare COVID-19 side effect

December 7, 2021 Manufacturing and Production

Most young people under the age of 21 who develop suspected COVID-19 myocarditis (inflammation of the muscle), show mild symptoms …
News

GSK antibody treatment effective against Omicron, study suggests

December 7, 2021 Manufacturing and Production

GlaxoSmithKline Plc have shared that research shows its antibody treatment is effective against the range of mutations in the recently-emerged …
News

Acadia Pharmaceuticals achieve positive Phase III results in Rett Syndrome trial

December 7, 2021 Manufacturing and Production

Acadia Pharmaceuticals have announced positive top-line results from the pivotal, Phase III Lavender study, which evaluated the efficacy and safety …
News

FDA approves new drug for identification of ovarian cancer

November 30, 2021 Manufacturing and Production

The FDA announced the approval of pafolacianine, marketed as Cytalux, a new drug which could help doctors detect ovarian cancer …
News

FDA plans fast approvals for Omicron-targeting vaccines

November 30, 2021 Manufacturing and Production

Joe Biden has directed the FDA and CDC to respond quickly to applications for vaccines or boosters to shield against …
News

NICE recommends Tagrisso (osimertinib) in England for lung cancer patients

November 30, 2021 Manufacturing and Production

AstraZeneca have announced that Tagrisso (osimertinib) is now available as an adjuvant treatment option to patients in England with completely …
News

FDA approves Livtencity as first treatment for drug-resistant post-transplant infection

November 24, 2021 Manufacturing and Production, Research and Development

The FDA have approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients with a common type …
News

Santhera and ReveraGen announce positive results from VISION-DMD study

November 23, 2021 Manufacturing and Production

Santhera Pharmaceuticals and ReveraGen BioPharma have announced new topline results after completion of the VISION-DMD study at week 48.
News

Sterling Pharma Solutions announces £10m investment to increase manufacturing capacity

November 23, 2021 Manufacturing and Production

Contract development and manufacturing organisation Sterling Pharma Solutions has announced a £10m multi-year investment strategy for its site in Dudley, …
News

European Commission approves BYANNLI for management of schizophrenia in adults

November 23, 2021 Manufacturing and Production

Johnson & Johnson have announced the approval of the long-acting atypical antipsychotic therapy BYANNLI® by the European Commission (EC), for …
News

Breakthrough personalised T-cell therapy for children with brain tumours

November 23, 2021 Manufacturing and Production

The Centre for Cancer and Immunology Research, Children’s National Research Institute, have developed a new approach that identifies unique proteins …
News

Orexo’s new drug effective against opioid overdoses

November 16, 2021 Manufacturing and Production

Orexo announced it has successfully completed the trial for its lead pharmaceutical pipeline asset, OX124, designed to help patients in …
News

Moderna announce promising study in mRNA drug for heart failure

November 16, 2021 Manufacturing and Production

The biotechnology company Moderna have announced positive data from the AstraZeneca-led Phase IIa EPICCURE trial, evaluating the use of a …
News

Revelar Biotherapeutics launches for development of COVID-19 and other antibody therapeutics

November 16, 2021 Manufacturing and Production

Twist Bioscience Corporation announced that it has launched Revelar Biotherapeutics, an independently operated, new biotechnology company to develop and commercialise …
News

Latest content

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024